LON:OPTI OptiBiotix Health (OPTI) Share Price, News & Analysis GBX 19.86 +1.86 (+10.31%) As of 05/2/2025 11:23 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsHeadlinesBuy This Stock About OptiBiotix Health Stock (LON:OPTI) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get OptiBiotix Health alerts:Sign Up Key Stats Today's Range 18.02▼ 20.4950-Day Range 14.80▼ 19.8652-Week Range 10▼ 35Volume300,003 shsAverage Volume251,583 shsMarket Capitalization£19.45 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewOptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome - the collective genome of the microbes in the body - in order to prevent and manage human disease and promote wellness. OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks. OptiBiotix is also developing its own range of consumer supplements and health products. The Company's current areas of focus include obesity, cardiovascular health, and diabetes. This communication is a "Reach" announcement. Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained in this announcement is of a non-regulatory nature. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on RNS Reach.Read More… Receive OPTI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for OptiBiotix Health and its competitors with MarketBeat's FREE daily newsletter. Email Address OPTI Stock News HeadlinesYork biotech company appoints new finance directorJanuary 17, 2025 | msn.comUndervalued Opportunities UK Penny Stocks To Watch In December 2024December 6, 2024 | uk.finance.yahoo.comThe Man I Turn to In Times Like ThisA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when publisher Brett Aitken turns to Whitney Tilson—a man CNBC once dubbed “The Prophet.” Tilson just released a new prediction that runs counter to what mainstream finance is telling you.May 3, 2025 | Stansberry Research (Ad)OptiBiotix Health Share Chat (OPTI)November 1, 2024 | lse.co.ukOptiBiotix Health Updates Shareholders on Voting RightsOctober 24, 2024 | msn.comTRADING UPDATES: LMS Capital NAV falls; Cloudcoco sells unitOctober 19, 2024 | lse.co.ukOptibiotix Health PLC (OPTIO)October 3, 2024 | investing.comOptiBiotix Health Plc (OB3.SG)September 25, 2024 | finance.yahoo.comSee More Headlines OPTI Stock Analysis - Frequently Asked Questions How have OPTI shares performed this year? OptiBiotix Health's stock was trading at GBX 18.05 at the beginning of the year. Since then, OPTI shares have increased by 10.0% and is now trading at GBX 19.86. View the best growth stocks for 2025 here. How were OptiBiotix Health's earnings last quarter? OptiBiotix Health Plc (LON:OPTI) released its earnings results on Thursday, September, 24th. The company reported ($0.70) earnings per share (EPS) for the quarter. OptiBiotix Health had a negative net margin of 524.43% and a negative trailing twelve-month return on equity of 36.76%. How do I buy shares of OptiBiotix Health? Shares of OPTI stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of OptiBiotix Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that OptiBiotix Health investors own include SkinBioTherapeutics (SBTX), IQE (IQE), Oracle (ORCL), Digital Globe Services (DGS), Derwent London (DLN), Petrofac (PFC) and IP Group (IPO). Company Calendar Last Earnings9/24/2020Today5/03/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryPharmaceutical Products Current SymbolLON:OPTI Previous SymbolLON:CMI CIKN/A Webwww.optibiotix.com Phone+44-20-79338780FaxN/AEmployees1Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (3.16) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-3,094,178.44 Net Margins-524.43% Pretax MarginN/A Return on Equity-36.76% Return on Assets-13.93% Debt Debt-to-Equity RatioN/A Current Ratio6.18 Quick Ratio7.89 Sales & Book Value Annual Sales£590,009.23 Price / Sales32.96 Cash FlowGBX 2.29 per share Price / Cash Flow8.68 Book ValueGBX 7.80 per share Price / Book2.55Miscellaneous Outstanding Shares97,943,197Free FloatN/AMarket Cap£19.45 million OptionableNot Optionable Beta1.71 Elon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free Report This page (LON:OPTI) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredWhat President Trump’s Executive Order 14154 means for your moneyNearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a f...Stansberry Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OptiBiotix Health Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share OptiBiotix Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.